Cargando…
Comparison of the efficacy and safety of CELBESTA® versus CELEBREX® in patients with rheumatoid arthritis: a 6-week, multicenter, double-blind, double-dummy, active-controlled, randomized, parallel-group, non-inferiority phase 4 clinical trial
OBJECTIVES: Celecoxib is a selective cyclooxygenase (COX)-2 inhibitor that is commonly used to reduce the incidence of gastrointestinal (GI) complications in patients with rheumatoid arthritis (RA). CELBESTA® is a generic equivalent to CELEBREX®, a celecoxib preparation. This study compared the effi...
Autores principales: | Kim, Hyun-Sook, Choi, Won-Ho, Kim, Bo Young, Kim, Sung Soo, Lee, Sang-Il, Kim, Sang-Hyon, Choi, Sung Jae, Kim, Geun-Tae, Hur, Jin-Wuk, Lee, Myeung-Su, Kim, Yun Sung, Hong, Seung-Jae |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7325469/ https://www.ncbi.nlm.nih.gov/pubmed/32589073 http://dx.doi.org/10.1177/0300060520931323 |
Ejemplares similares
-
Comparison of Two pMDIs in Adult Asthmatics: A Randomized Double-Blind Double-Dummy Clinical Trial
por: Nam, Tae-Hyun, et al.
Publicado: (2022) -
Efficacy and Safety of Naftopidil in Patients With Neurogenic Lower Urinary Tract Dysfunction: An 8-Week, Active-Controlled, Stratified-Randomized, Double-Blind, Double-Dummy, Parallel Group, Noninferiority, Multicenter Design
por: Sung, Hyun Hwan, et al.
Publicado: (2020) -
A Randomized Double-Blind, Double-Dummy, Multicenter Trial of Azasetron versus Ondansetron to Evaluate Efficacy and Safety in the Prevention of Delayed Nausea and Vomiting Induced by Chemotherapy
por: Lee, Hee Yeon, et al.
Publicado: (2014) -
How to improve patient satisfaction during midazolam sedation for gastrointestinal endoscopy?
por: Jin, Eun Hyo, et al.
Publicado: (2017) -
Gender differences in ghrelin, nociception genes, psychological factors and quality of life in functional dyspepsia
por: Choi, Yoon Jin, et al.
Publicado: (2017)